Dec 3- A former hedge-fund analyst who argued that Dendreon Corp's therapeutic vaccine for prostate cancer may hasten the death of patients has reached a settlement with U.S. securities regulators over failure to disclose her financial interests in the company.» Read More
**GOLDMAN SACHS GROUP INC, $164.24, up 2.9 pct. **NIKE INC, $66.73, up 2 pct.
FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS. **ALAMOS GOLD INC, $15.59, down 4 pct. **GOLDCORP INC, $27.98, down 4 pct.
U.S. stocks advanced at the open on Tuesday, putting the S&P 500 on pace for a sixth day of gains, following further upbeat economic data from China and as an alternative solution emerged to a possible Western military strike against Syria. **ALAMOS GOLD INC, $15.59, down 4 pct.
**APPLE INC, Monday close $506.17, up 0.5 pct premarket. Apple is expected to introduce a cheaper version of the iPhone on Tuesday, bringing one of the industry's costliest smartphones within reach of the masses in poorer emerging markets. **GOLDMAN SACHS GROUP INC, Monday close $159.49, up 2.7 pct premarket.
*FDA review of Glaxo/ Theravance drug backs efficacy. *FDA notes some inconsistencies in safety data. The report, written by FDA reviewer Dr Jennifer Rodriguez Pippins, notes that the drug appears to work at the dose proposed by the company, but that the safety database, while large, is "not entirely conclusive, particularly in regards to cardiovascular safety."
*MAGE-A3 vaccine fails to extend disease-free survival in trial. LONDON, Sept 5- An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project.
LONDON, Sept 5- An experimental cancer vaccine from GlaxoSmithKline failed to meet the first of two joint targets in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project.
Metal workers 2,000 years ago perfected plating techniques that modern methods can't touch. Some probably coated cheap metal or wood objects in a gilded skin and sold them for big profits. NBC reports.
NEW YORK, July 12- Swiss pharmaceutical company Roche Holding AG is seeking financing for a potential takeover of Alexion Pharmaceuticals Inc, a transaction that would be the largest healthcare deal of the year, two people familiar with the matter said on Friday.
July 12- Eli Lilly and Co plans this year to begin a new late-stage trial of solanezumab, its experimental treatment for Alzheimer's disease that failed in earlier testing to significantly slow progression of the memory-robbing disease, the U.S. drugmaker said on Friday.
The number of women choosing to have preventive mastectomies has risen by almost 50 percent in recent years, and surveys show they are happy with the decision.
China has earned praise from international scientists for its handling of an outbreak of a deadly new bird flu, but a history of public health cover-ups means the Chinese public is harder to win over.
A strain of bird flu that has been found in humans for the first time in eastern China is not a cause for panic, the World Health Organization said on Monday, even as the number of people infected rose to 21, with six deaths.
CNBC's Jon Fortt speaks with Facebook founder & CEO Mark Zuckerberg and Apple Chairman Art Levinson about a new foundation to offer a $33 million prize for life science research. "We all think our society needs more heroes who are scientists, researchers and engineers," he says.
Japan has one of the world’s highest suicide rates. But last year the number of suicides fell below 30,000 for the first time in 15 years, thanks in part to community efforts. The CSM reports.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
The National Geographic Channel is preparing to beam tweets into space, in response to the "Wow! signal," a transmission received from space.
BGI, based in China, is the world’s largest genomics research institute, with 167 DNA sequencers producing the equivalent of 2,000 human genomes a day, the New York Times reports.
Scientists have discovered neural pathways that seem to correlate with the kinds of people who deal well with financial risk, but even the very definition of risk gets pulled apart by experts.
DSM Chairman and CEO Feike Sijbesma told CNBC he expects the Dutch chemicals firm to perform well in the second half of the year following strong second quarter results which saw a boost in net profit, while revenue fell just shy of the Reuters average forecast.